BNTX BioNTech
- 111.480
- -1.620-1.43%
- 111.480
- 0.0000.00%
BioNTech News
CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $171
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
BioNTech Is Maintained at Hold by TD Cowen
BioNTech Analyst Ratings
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
TD Cowen Maintains BioNTech(BNTX.US) With Hold Rating, Raises Target Price to $132
Cautious Long-term Growth Potential: Yaron Werber's Hold Rating on BioNTech SE
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
HSBC Initiates BioNTech(BNTX.US) With Buy Rating, Announces Target Price $136
BioNTech Is Maintained at Buy by HSBC
Morgan Stanley Upgrades BioNTech(BNTX.US) to Buy Rating, Raises Target Price to $145
BioNTech Analyst Ratings
H.C. Wainwright Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $150
Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $150
BioNTech SE (BNTX) Gets a Buy From Deutsche Bank
UBS Maintains BioNTech(BNTX.US) With Hold Rating, Maintains Target Price $131
TD Cowen Reaffirms Their Hold Rating on BioNTech SE (BNTX)
BioNTech Analyst Ratings
Analysis
Price Target
No Data
No Data
